ArticleMetabolic brain disease2025
Intrauterine growth restriction (IUGR) modifies the hypothalamic response to a systemic glucose load in adult male rats, as assessed by proteomic analysis.
Article in Metabolic brain disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have previously demonstrated that 4-month-old IUGR male rats had obesity, hyperglycemia, and increased hypothalamic glucose levels, indicative of disruption of hypothalamic glucose metabolism. To evaluate, by proteomic analysis, the hypothalamic response to a systemic glucose load before the development of IUGR-induced obesity. Wistar rats were fed either ad libitum (Control group, C) or received 50% of C intake throughout pregnancy (Restricted group, R), and fed ad libitum during lactation. The male C and R offspring were fed ad libitum from weaning to 3-months-old. They were injected intraperitoneally with either saline (CS and RS) or 2 g/kg glucose (CG and RG) (n = 4 each), euthanized after 45 min., and had their hypothalami harvested. Pathway search was conducted with significantly modulated proteins (Student's t-test, p < 0.05). When comparing CS and RS, the tricarboxylic acids cycle and the respiratory chain pathways had multiple down-regulated proteins. Comparing CG and RG, while these pathways were also affected, only pyruvate dehydrogenase complex (PDH) (Fold change (FC) 0.63) was down-regulated while citrate synthase (FC 1.43) and respiratory chain complex I (FC 1.63) were up-regulated. This could represent a compensatory response aimed at overcoming the down-regulation of the respiratory chain induced by IUGR. These seemingly beneficial responses may, however, induce increased reactive oxidative species, insulin resistance and obesity. The results suggest that, even before the establishment of obesity and hyperglycemia, IUGR may have impacted metabolic pathways and the hypothalamic response to a systemic glucose load, that in the long term, could have a negative impact on energy homeostasis.
Indexed as
Identifiers
40879804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.